Dallas Dangerous Drug Injury Lawyer
Written by: Hastings Law Firm | Reviewed by: Tommy Hastings | Updated: May 6, 2026
Medication related harm can be especially upsetting because it often follows a decision made in good faith to get better. Pharmaceutical injury claims can involve negligent prescribing or dispensing by a healthcare provider, a defective drug, or inadequate warnings from a manufacturer, and the distinction can shape responsibility and available damages. These cases often turn on careful review of medical records, the physical medication, and expert analysis to connect the drug to the injury and its long term effects. If you or a loved one were harmed or worse due to pharmaceutical injuries in Dallas, Texas, contact Hastings Law Firm for a free, confidential case review.

Trusted Medical Liability Attorneys for Pharmaceutical Injuries in Dallas
What You Should Know About Medication Side Effect Claims in Dallas:
- Recovery can depend on whether the harm is tied to negligent prescribing or dispensing versus a defective drug, since the responsible parties and proof differ.
- Options can narrow when a claim is treated as medical malpractice rather than product liability, because Texas limits non economic damages in malpractice cases.
- Accountability can involve multiple entities at once, including manufacturers, physicians, pharmacies, and hospitals, when errors overlap across the medication chain.
- Severe outcomes can occur when known risks are not disclosed, since failure to warn allegations focus on inadequate labels or withheld safety information.
- Proof can be lost if the medication is returned or exchanged, because preserving the bottle, packaging, and remaining pills can be central to contamination or dispensing error claims.
- Establishing causation can require specialized expert analysis, since it must link the drug and dose to the specific physiological injury.
- Resolution can be affected by common manufacturer defenses, including federal preemption arguments and efforts to shift responsibility to the prescriber.
- Evidence strength can hinge on complete documentation, including pharmacy dispensing records and medical records that reflect prescribing history and monitoring.

A Healthcare Focused Law Firm
When a medication you trusted to help you causes unexpected harm, it can feel like the system designed to protect your health has failed you. That sense of betrayal is real, and you have every right to question what went wrong. Pharmaceutical injury cases sit at the intersection of medical malpractice and product liability, requiring a legal team with deep clinical knowledge and litigation experience to identify who is responsible. Understanding these legal intersections is the first step toward recovery.
At Hastings Law Firm, our team of attorneys, in-house nurse consultants, and former defense lawyers focuses exclusively on medical negligence and pharmaceutical harm. Founded by Tommy Hastings, who is Board Certified in Personal Injury Trial Law by the Texas Board of Legal Specialization, our firm understands both the medicine and the law behind these claims. If you or a loved one has been harmed by a dangerous or defective medication, we offer a free, confidential case evaluation to review what happened and explain your options.
Understanding Pharmaceutical Injury Claims in Dallas
A prescription drug injury claim is a legal action seeking compensation for harm caused by defective medications, improper prescribing, or pharmacy dispensing errors. This field of law involves both clinical care standards and manufacturing safety. Such a legal action can be filed against different parties depending on the source of the problem, and they generally fall under two distinct legal categories: medical malpractice or product liability.
A medical malpractice claim targets the healthcare provider. This applies when a physician prescribes the wrong drug, ignores a known allergy, fails to monitor for adverse drug reactions (ADR), or makes a dosage error. Proving this breach requires detailed analysis of clinical decisions to determine if the doctor or nurse met the accepted standard of care.
A product liability claim, on the other hand, targets the drug manufacturer. This applies when the drug itself is defective or when the manufacturer engaged in failure to warn, meaning it provided inadequate warning labels or withheld known risks from doctors and patients. Texas law, including provisions in the Civil Practice and Remedies Code (Texas Legislature Online), addresses how liability attaches in pharmaceutical product cases, often demanding rigorous evidence to link the defect to the injury.
The distinction matters because it changes who you sue, what you need to prove, and what evidence your prescription drug injury lawyer in Dallas will need to build your case. Handling these concurrent legal standards demands a strategy that addresses both the clinical negligence and the corporate liability aspects simultaneously.
| Medical Malpractice Claim | Defective Drug (Product Liability) Claim | |
|---|---|---|
| Who Is Sued | Prescribing physician, pharmacist, nurse, or hospital | Drug manufacturer, distributor, or pharmacy |
| Standard of Proof | Breach of the medical standard of care | Strict liability or negligence in design, manufacturing, or marketing |
| Typical Evidence | Medical records, prescribing history, expert testimony on clinical decisions | FDA filings, internal company documents, clinical trial data, adverse event reports |
In many cases, both types of claims overlap. A patient may have been prescribed a drug negligently by a physician while also taking a medication with a known, undisclosed defect. That complexity is exactly why these cases require a firm with specialized medical and legal resources.

Types of Defective Drug and Medication Error Claims
Claims in pharmaceutical injury cases typically fall into categories such as design defects, manufacturing defects, marketing defects (failure to warn), or clinical negligence like medication errors and pharmacy mistakes. Identifying the category of error is the first step in determining who is legally responsible for your injury.
- Design defects occur when a drug is inherently dangerous even when manufactured and used exactly as intended. The flaw exists in the drug’s chemical formula or molecular structure itself. If the risks outweigh the benefits for the intended patient population, the manufacturer may be liable regardless of how carefully the drug was produced.
- Manufacturing defects involve contamination or errors introduced during the production process. A manufacturing defect means something went wrong at the factory level. This could include contamination with foreign substances, incorrect ingredient concentrations, or improper storage that degrades the drug’s composition. This category highlights how a safe design can become a dangerous product through factory-level errors.
- Failure to warn claims arise when a drug manufacturer does not disclose known risks or provides inadequate safety information to physicians and patients. If clinical trials or post-market data revealed dangerous side effects and the manufacturer did not update its warnings, patients who suffered those exact adverse reactions may have a claim.
- Clinical errors by physicians and pharmacists represent the medical malpractice side of pharmaceutical injury. A physician who prescribes a medication that is contra-indicated based on a patient’s existing conditions or current medications, or a pharmacist who dispenses the wrong pill or incorrect dosage, may each bear individual liability for the resulting harm. These claims often hinge on proving the provider deviated from safety protocols.
Some cases involve more than one of these categories at the same time. A contaminated batch of medication dispensed by a pharmacy that also failed to verify dosage creates overlapping claims against multiple parties.
The Hastings Law Firm Difference
Results matter, but what truly sets us apart is how we achieve them. Every verdict, every settlement, and every Dallas courtroom victory comes from one guiding promise: To treat each client’s fight for justice as if it were our own.
This balance of skill, experience, and empathy reflects our core philosophy that justice should not only compensate the injured, but also make healthcare safer nationwide.

Liability in Pharmaceutical Cases From Manufacturers to Pharmacists
Liability can extend to drug manufacturers for defects, physicians for negligent prescribing, pharmacies for dispensing errors, or hospitals for medication administration mistakes. Determining who is responsible requires a detailed look at the chain of distribution. In pharmaceutical injury cases, responsibility is rarely limited to a single party, and identifying every liable entity is essential to building a complete claim.
Drug manufacturers can face strict liability for placing a dangerous product on the market. This means a patient does not necessarily need to prove the manufacturer was careless. They need to prove the drug was defective and that the defect caused their injury.
Prescribing physicians have a duty to review your medical history, check for contraindications, and monitor for drug-drug interactions. These interactions occur when two or more medications interfere with each other in harmful ways. When a doctor overlooks a known allergy or prescribes a medication that conflicts with your current prescriptions, that physician may be individually liable.
Pharmacies and pharmacists are a critical safety checkpoint. When a pharmacist fills the wrong medication, dispenses an incorrect dosage, or fails to flag a dangerous interaction that appears in the prescription records, the pharmacy can be held responsible.
Hospitals bear liability when nursing staff administers a medication incorrectly, whether through the wrong route, wrong timing, or wrong patient. Institutional failures in medication protocols can compound individual errors.
Our legal team includes former defense lawyers who understand the tactics used by hospital and pharmaceutical insurance carriers. Working with in-house medical staff, we trace exactly where the breakdown occurred. Because defendants often try to shift blame to one another, having a team that understands the full chain of pharmaceutical negligence is critical to protecting your claim.

Immediate Steps to Take After a Suspected Medication Injury
Victims should immediately preserve the remaining medication, seek independent medical evaluation, request their medical records, and avoid speaking to insurance adjusters before legal consultation. Acting quickly helps ensure clinical evidence is not lost. Taking the right steps early can protect both your health and your legal options.
- Preserve the medication. Keep the pill bottle, remaining pills, packaging, and receipts. Store everything in a safe place exactly as it is to prevent loss or damage.
- Seek immediate medical attention. See a doctor unconnected to the original prescriber. This creates an independent medical record documenting your adverse reactions and establishes a timeline.
- Request your medical records. Ask for copies of your prescribing records, pharmacy logs, and hospital notes. Obtaining them early prevents gaps or delays in evidence gathering.
- Document everything. Start a written journal of your symptoms, including dates, severity, and how they affect your daily life.
- Report the event. You can file a report through MedWatch Forms for FDA Safety Reporting (U.S. Food and Drug Administration), the FDA’s voluntary safety reporting program that allows patients to report serious problems.
- Do not sign anything. Insurance adjusters may contact you quickly. Do not accept settlement offers before speaking with a Dallas prescription drug injury attorney who can evaluate your claim.
Specific Guidance on Preserving Evidence
In a pharmaceutical injury case, the physical medication is often the most important piece of evidence. Proper evidence preservation is necessary. Do not hand the pill bottle back to the pharmacy for a “return” or “exchange.” Pharmacies are not required to preserve returned medications for you, and this breaks the pharmacy chain of custody.
If the claim involves contamination, independent testing of the actual pills you received may be the only way to prove your case. Photograph the bottle, label, and lot number, and store the physical medication separately. Proper handling of physical evidence is critical to proving the source of a medication error.

How We Investigate and Prove Causation in Drug Cases
We work with toxicologists, pharmacologists, and medical experts to scientifically link the chemical composition of the drug to the specific physiological injury you suffered. Linking a medication to an injury requires specific clinical proof. Proving causation in pharmaceutical cases requires more than showing that you took a drug and then got sick. We need to demonstrate the direct connection between the two.
Our investigation starts with a thorough review of your medical records. Our in-house nursing staff examines prescribing histories, dosage changes, lab results, and clinical notes to identify charting inconsistencies or gaps in monitoring. If a physician failed to order routine blood work while prescribing a high-risk medication, that omission becomes part of the evidence. The CDC’s guidance on prescription medicine safety and storage offers additional context on proper handling standards, which aligns with FDA protocols.
When contamination or a manufacturing defect is suspected, we may arrange independent testing of the medication itself. Expert pharmacologists can analyze the drug’s chemical composition and compare it to the manufacturer’s specifications to determine whether what you received matches what was approved.
Expert testimony is central to these cases. Our national network of expert witnesses provides objective analysis of whether the drug, at the dose prescribed, is capable of causing the specific injury you experienced. This is the causation bridge that connects the medication to the harm.
Using the NCCMERP Scale to Classify Severity
We also use the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) Index, a standardized classification system that categorizes medication errors by error severity from Category A through Category I. As a legal team, we use this framework to clearly document if the error resulted in permanent harm or death. Classifying the injury on a recognized medical scale strengthens the case by grounding the claim in objective, widely accepted criteria.
Common Dangerous Drugs in Pharmaceutical Litigation
Pharmaceutical litigation frequently involves opioids, blood thinners, and drugs with undisclosed side effects like severe internal bleeding or cardiac events. While many drugs are safe, litigation often focuses on medications that caused systemic harm across large patient populations. Litigation in these categories often identifies systemic failures in safety testing.
Opioids remain one of the most litigated categories due to widespread overprescribing and manufacturer misrepresentation of addiction risks. Blood thinners like Xarelto and Pradaxa have generated thousands of claims after patients suffered uncontrollable bleeding episodes that were not adequately disclosed. SSRIs and other antidepressants have been linked to birth defects when taken during pregnancy, and several manufacturers faced allegations of suppressing that data. The FDA Adverse Event Reporting System (FAERS) tracks these reports and can provide supporting evidence in litigation.
When a dangerous drug injures large numbers of people across the country, cases are often consolidated into Multidistrict Litigation (MDL). This federal process groups similar lawsuits before a single judge to streamline pretrial proceedings. The Judicial Panel on Multidistrict Litigation (JPML) decides which cases qualify. MDL is not a class action; each person retains their individual claim, but the process allows for more efficient handling of shared legal and scientific questions.
Critique of Flaws in FDA Approval and Regulation
FDA approval does not guarantee a drug is safe for everyone. Fast-track approval pathways can allow medications to reach the market with limited long-term data, a process often criticized as an FDA loophole. Sometimes a drug recall is issued only after significant harm occurs. Post-market surveillance, the ongoing monitoring of a drug’s safety after it has been approved, sometimes reveals risks that were not apparent during clinical trials.
Damages You Can Recover in a Drug Injury Lawsuit
Patients harmed by a dangerous or defective medication may recover economic damages for medical bills and lost wages, as well as non-economic damages for pain, suffering, physical impairment, and disfigurement. Compensation in these lawsuits aims to cover both measurable financial losses and the personal impact of the injury. These funds help a patient manage the long-term consequences of a medication error.
Economic damages cover the measurable financial losses caused by the injury. This includes past and future medical expenses, rehabilitation costs, prescription costs for corrective treatment, and lost earning capacity if the injury affects your ability to work. In severe cases, calculations often involve economists to project lifetime costs for ongoing care or in-home assistance.
Non-economic damages address the personal toll that does not come with a receipt. Chronic pain, emotional distress, loss of enjoyment of life, physical disfigurement, and the strain on your closest relationships all factor into this category. Texas law acknowledges these intangible losses, which reflect the real impact of the injury on your daily life.
Wrongful death damages apply when a medication injury results in the loss of a loved one. Surviving family members may seek compensation for funeral expenses, loss of financial support, loss of companionship, and mental anguish. Texas law allows specific family members to bring these claims on behalf of the deceased.
Every case is different, and the damages available depend on the severity of the injury, the type of claim, and the parties involved. Our team evaluates the full scope of harm to pursue the compensation that reflects what you and your family have actually lost.
Contact the Dallas Dangerous Drug Attorneys at Hastings Law Firm Today for Help
If you or a loved one has suffered harm from a prescription medication, you deserve honest answers about what happened and whether you have a legal claim. Our team reviews your medical history to identify where the negligence occurred. We use a strategic preparation approach to hold manufacturers and providers accountable.
Our firm focuses exclusively on medical liability. We believe that every case is also an opportunity to prevent the same harm from happening to someone else. That principle drives everything we do.
We offer a free, confidential case evaluation, and you pay no attorney fees unless we recover compensation for you. Contact Hastings Law Firm today to speak with a member of our team and take the first step toward understanding your options.
Frequently Asked Questions About Dangerous Drug Injury in Dallas

Key Dangerous Drug Injury Terms:
- Adverse drug reaction (ADR)
- An unexpected or harmful response to a medication taken at the normal dose. In pharmaceutical injury claims, an ADR can form the basis of a lawsuit if the manufacturer failed to warn doctors and patients about the known risk, or if a healthcare provider prescribed the drug despite warning signs that the patient would have a dangerous reaction.
- Failure to warn (inadequate warning label)
- A legal claim against a drug manufacturer for not providing sufficient information about a medication’s risks and side effects. This occurs when the company knew or should have known about dangers but failed to include clear warnings on the label or in materials given to doctors, preventing patients and physicians from making informed decisions about the drug’s use.
- Design defect
- A flaw in the fundamental formula or composition of a drug that makes it unreasonably dangerous, even when manufactured and used exactly as intended. In defective drug claims, a design defect means the medication’s risks outweigh its benefits, and a safer alternative design was feasible when the drug was created.
- Manufacturing defect (contamination)
- An error that occurs during the production process of a medication, resulting in a batch that differs from the intended design. Contamination can include foreign substances, incorrect ingredients, or improper dosage strength. In pharmaceutical injury cases, these defects can cause serious harm even though the drug’s design itself may be safe.
- Contraindication
- A medical condition, factor, or circumstance that makes it unsafe to use a particular drug because it could cause serious harm. In pharmaceutical liability cases, prescribing a medication despite a known contraindication—such as giving a blood thinner to someone with active bleeding—can establish that a doctor or pharmacist failed to meet the standard of care.
- Drug–drug interaction
- A reaction that occurs when two or more medications taken together affect how each drug works, potentially causing dangerous side effects or reducing effectiveness. In liability cases involving manufacturers and prescribers, failing to warn about known interactions or failing to check a patient’s medication list before prescribing can support a claim of negligence.
- MedWatch (FDA Safety Reporting)
- The Food and Drug Administration’s system for healthcare professionals and the public to report serious adverse events, product quality problems, and medication errors. After a suspected medication injury, filing a MedWatch report creates an official government record that can serve as evidence in a pharmaceutical injury lawsuit and helps the FDA identify dangerous drugs that need warnings or recalls.
- National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) Index
- A standardized scale used to classify medication errors based on their severity, ranging from Category A (circumstances that could lead to an error) to Category I (error that contributed to patient death). This index helps document the seriousness of a medication injury and can be used as evidence to demonstrate the level of harm caused in a pharmaceutical negligence or malpractice case.
- Post-market surveillance
- The ongoing monitoring of a drug’s safety after it has been approved and released to the public. This includes tracking adverse event reports, conducting studies, and analyzing real-world use. In pharmaceutical injury cases, evidence that a manufacturer failed to properly conduct post-market surveillance or ignored emerging safety signals can demonstrate negligence or concealment of known dangers.
- Fast-track approval
- An expedited FDA review process that allows drugs for serious conditions to reach the market more quickly, often with less long-term safety data than standard approvals. In pharmaceutical liability cases, fast-track approval can be relevant when arguing that a drug was released without adequate testing, leading to undiscovered risks that later harmed patients.
- SB 1521 Bill Text Introduced Version | Texas Legislature Online
- MedWatch Forms for FDA Safety Reporting | U.S. Food and Drug Administration
- Your Prescription Medicine Tips for Safe Storage and Disposal | CDC
- FDA Adverse Event Reporting System FAERS Essentials A Guide to Understanding Applying and Interpreting Adverse Event Data Reported to FAERS | PubMed Central
- Inside the JPML | Judicature
- Civil Practice and Remedies Code | Texas Legislature Online
- Open Payments Data Overview | CMS

This content was researched and written by the Hastings Law Firm editorial team, which includes attorneys, medical professionals, and experienced researchers. Our writing is informed by internal knowledge and practical experience, and we cross-check critical details against authoritative sources cited throughout. Every piece undergoes human-led fact-checking and legal review. Because legal and medical information can change, if you spot an error, please contact us. Learn more about our content standards and review process on our editorial policy page.

Tommy Hastings, founder of Hastings Law Firm, is a board-certified personal injury trial lawyer dedicated exclusively to healthcare injury cases. Since 2001, he has represented injured patients and families in litigation against major hospital systems, pharmaceutical companies, and negligent healthcare providers nationwide. He has handled numerous high-profile cases that have drawn national media attention and resulted in multi-million dollar recoveries. He draws on that experience in his writing, helping readers understand how these cases work and what options may be available to them.
Get Answers Today
If you think that medical negligence, a dangerous drug, or a failed medical product caused harm to you or someone you love, our team is standing by to offer guidance. We’ll explain your options under current laws and help you move forward with clarity and understanding. Case reviews are free and 100% confidential.
